Protalex to Present at Pacific Growth Equities 2005 Life Sciences Conference

    NEW HOPE, Pa., June 1 /PRNewswire-FirstCall/ -- Protalex, Inc.
 (OTC Bulletin Board:   PRTX) announced today that Steven H. Kane, President and
 Chief Executive Officer of Protalex, Inc. will present at the Pacific Growth
 Equities 2005 Life Sciences Conference at the Intercontinental Mark Hopkins
 Hotel in San Francisco, CA.
     Mr. Kane is scheduled to speak on Tuesday, June 7, 2005 at 9:30AM Pacific
 Time.
 
     About Protalex, Inc.
     Protalex is a biotechnology company engaged in the development of a new
 class of drug for the treatment of Rheumatoid Arthritis, Pemphigus and other
 autoimmune diseases.
 
     Protalex assumes no obligation to update any forward-looking statements or
 information set forth in its Press Releases.  Protalex's actual results could
 differ materially from those described in Protalex's Press Releases.  Factors
 that could cause or contribute to such differences include, but are not
 limited to, those discussed in detail under the heading "Risk Factors" in
 Protalex's Post Effective Amendment No. 3 to the Registration Statement on
 Form SB-2 filed with the SEC on March 15, 2005 and other periodic reports
 filed with the SEC.  These risks should be considered only in connection with
 the fully discussed risks and other factors discussed in detail in the
 aforementioned registration statement and Protalex, Inc.'s other periodic
 reports filed with the SEC.
 
 

SOURCE  Protalex, Inc.